At the time of writing, Procept BioRobotics Corp [PRCT] stock is trading at $61.63, up 2.74%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PRCT shares have gain 5.10% over the last week, with a monthly amount glided 13.27%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Procept BioRobotics Corp [NASDAQ: PRCT] stock has seen the most recent analyst activity on December 02, 2024, when Morgan Stanley initiated its Overweight rating and assigned the stock a price target of $105. Previously, Jefferies started tracking the stock with Hold rating on November 14, 2024, and set its price target to $95. On August 11, 2023, Piper Sandler initiated with a Overweight rating and assigned a price target of $42 on the stock. William Blair started tracking the stock assigning a Outperform rating. BTIG Research initiated its recommendation with a Neutral. Truist started tracking with a Buy rating for this stock on October 25, 2022, and assigned it a price target of $58. In a note dated September 02, 2022, Wells Fargo initiated an Overweight rating and provided a target price of $49 on this stock.
For the past year, the stock price of Procept BioRobotics Corp fluctuated between $47.04 and $103.81. Currently, Wall Street analysts expect the stock to reach $83.5 within the next 12 months. Procept BioRobotics Corp [NASDAQ: PRCT] shares were valued at $61.63 at the most recent close of the market. An investor can expect a potential return of 35.49% based on the average PRCT price forecast.
Analyzing the PRCT fundamentals
According to Procept BioRobotics Corp [NASDAQ:PRCT], the company’s sales were 249.12M for trailing twelve months, which represents an 55.28% jump. Gross Profit Margin for this corporation currently stands at 0.62% with Operating Profit Margin at -0.39%, Pretax Profit Margin comes in at -0.36%, and Net Profit Margin reading is -0.36%. To continue investigating profitability, this company’s Return on Assets is posted at -0.17, Equity is -0.28 and Total Capital is -0.21. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Procept BioRobotics Corp [NASDAQ:PRCT] has a current ratio of 8.94. As well, the Quick Ratio is 7.74, while the Cash Ratio is 6.07. Considering the valuation of this stock, the price to sales ratio is 13.69, the price to book ratio is 8.75.
Transactions by insiders
Recent insider trading involved 222 DNA TRUST, Director, that happened on Jun 03 ’25 when 0.15 million shares were purchased. President, CEO, Zadno Reza completed a deal on Mar 18 ’25 to sell 5475.0 shares. Meanwhile, EVP, CFO Waters Kevin sold 733.0 shares on Mar 18 ’25.
